1
|
Fong S, Mahmood E, Sanabria B, Ouellette S, Rao BK. In Vivo Reflectance Confocal Microscopy Evaluation of Microneedle Patch Penetration Depth. J Drugs Dermatol 2023; 22:1107-1110. [PMID: 37943270 DOI: 10.36849/jdd.6994] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2023]
Abstract
BACKGROUND Firstly, confirm penetration of the skin's most exclusive layer, the stratum corneum (SC), by commercially available microneedle patches using reflectance confocal microscopy (RCM). Secondly, determine the deepest layer of the skin penetrated by the microneedle patches. MATERIALS AND METHODS In this proof-of-concept study, 3 commercially available dissolving microneedle patches with different active ingredients were included in this study. RCM images of the cheek were taken prior to patch application at 4 different layers of the skin: stratum corneum, stratum spinosum-granulosum, dermal-epidermal junction, and papillary dermis. Patches were then applied to the cheeks of participants according to manufacturer guidelines. Immediately after removal, the same area and layers were imaged using RCM and assessed for features of penetration. RESULTS Micropores were visualized in RCM images of skin layers post-application of all patches when compared with imaging before application. Characteristics of penetration included uniformly sized, shaped, and spaced well-defined circular areas, which are the created micropores. All 3 patches penetrated the SC to the level of the papillary dermis. CONCLUSION This study confirms that the dissolving microneedle patches penetrate the most exclusive layer of the skin, the SC, down to the level of the papillary dermis as visualized through RCM. Confirming penetration with RCM shows the potential of these patches to be used for medication transmission. While future studies are needed to assess the efficacy of microneedle patches applied for their advertised skin conditions, confirming the penetration of the microneedle technology through RCM is a significant first step in this process. J Drugs Dermatol. 2023;22(11):1107-1110 doi:10.36849/JDD.6994.
Collapse
|
2
|
Natanov D, Avihai B, McDonnell E, Lee E, Cook B, Altomare N, Ko T, Chaia A, Munoz C, Ouellette S, Nyalakonda S, Cederbaum V, Parikh PD, Blaser MJ. Predicting COVID-19 prognosis in hospitalized patients based on early status. mBio 2023; 14:e0150823. [PMID: 37681966 PMCID: PMC10653946 DOI: 10.1128/mbio.01508-23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2023] [Accepted: 07/17/2023] [Indexed: 09/09/2023] Open
Abstract
IMPORTANCE COVID-19 remains the fourth leading cause of death in the United States. Predicting COVID-19 patient prognosis is essential to help efficiently allocate resources, including ventilators and intensive care unit beds, particularly when hospital systems are strained. Our PLABAC and PRABLE models are unique because they accurately assess a COVID-19 patient's risk of death from only age and five commonly ordered laboratory tests. This simple design is important because it allows these models to be used by clinicians to rapidly assess a patient's risk of decompensation and serve as a real-time aid when discussing difficult, life-altering decisions for patients. Our models have also shown generalizability to external populations across the United States. In short, these models are practical, efficient tools to assess and communicate COVID-19 prognosis.
Collapse
Affiliation(s)
- David Natanov
- Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA
| | - Byron Avihai
- Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA
| | - Erin McDonnell
- Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA
| | - Eileen Lee
- Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA
| | - Brennan Cook
- Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA
| | - Nicole Altomare
- Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA
| | - Tomohiro Ko
- Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA
| | - Angelo Chaia
- Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA
| | - Carolayn Munoz
- Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA
| | | | - Suraj Nyalakonda
- Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA
| | - Vanessa Cederbaum
- Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA
| | - Payal D. Parikh
- Department of Medicine, Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
| | - Martin J. Blaser
- Center for Advanced Biotechnology and Medicine, Rutgers University, New Brunswick, New Jersey, USA
| |
Collapse
|
3
|
Shah R, Ouellette S, Khan S, Truong T, Pappert A, Wassef C. Novel topical cyclosporine as adjuvant therapy for pyoderma gangrenosum: A case series. JAAD Case Rep 2023; 40:67-73. [PMID: 37731670 PMCID: PMC10507064 DOI: 10.1016/j.jdcr.2023.07.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/22/2023] Open
Affiliation(s)
- Radhika Shah
- Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Somerset, New Jersey
| | - Samantha Ouellette
- Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Somerset, New Jersey
| | - Samavia Khan
- Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Somerset, New Jersey
| | - Thu Truong
- Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Somerset, New Jersey
- Rutgers New Jersey Medical School, Newark, New Jersey
| | - Amy Pappert
- Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Somerset, New Jersey
| | - Cindy Wassef
- Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Somerset, New Jersey
| |
Collapse
|
4
|
Asim M, Shah R, Sharif S, Ouellette S, Shah A, Rao B. A Randomized Control Trial Comparing the Efficacy of Platelet-Rich Plasma and 5% Topical Minoxidil for the Treatment of Androgenetic Alopecia. J Drugs Dermatol 2023; 22:905-909. [PMID: 37683060 DOI: 10.36849/jdd.7031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/10/2023]
Abstract
Androgenetic alopecia (AGA) is the most common cause of hair loss in men and has limited treatment options. Minoxidil is a common therapeutic option for AGA patients because of its availability. Platelet-rich plasma (PRP) therapy is a newer option in AGA management with promising results that may be suitable for some patients. Despite a great prevalence of AGA outside the United States and Europe, there remains limited studies on the efficacy of PRP for AGA treatment. Our study's objective was to compare the efficacy of PRP and minoxidil therapy for the treatment of AGA in a Pakistani population. 72 patients were included in this randomized control trial and were either treated with PRP or topical minoxidil. After 12 weeks of treatment, the hair pull test was performed and extracted hair was counted. We report a 91.7% negative hair pull rate in the PRP treatment group which was significantly greater than the 69.4% negative hair pull rate in the minoxidil-treated group. Our study suggests that PRP therapy demonstrates a higher efficacy compared to minoxidil for treating AGA, especially in our patient demographic. These results have the opportunity to improve patient compliance and overall satisfaction while offering an improved option in patients unsatisfied with topical minoxidil. Citation: Shah R, Asim M, Ouellette S, et al. A randomized control trial comparing the efficacy of platelet-rich plasma and 5% topical minoxidil for the treatment of androgenetic alopecia. J Drugs Dermatol. 2023;22(9):905-909. doi:10.36849/JDD.7031.
Collapse
|
5
|
Razi S, Truong TM, Sekhon P, Ouellette S, Rao BK. Subacute cutaneous lupus erythematosus with a psoriasiform presentation: A diagnostic clinical conundrum. Clin Case Rep 2023; 11:e7893. [PMID: 37736481 PMCID: PMC10509344 DOI: 10.1002/ccr3.7893] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2023] [Revised: 07/05/2023] [Accepted: 08/25/2023] [Indexed: 09/23/2023] Open
Abstract
Key Clinical Message For practitioners experiencing worsening psoriasis, subacute cutaneous lupus erythematosus (SCLE) with a psoriasiform presentation should be ruled out. Initial treatment for a presumptive diagnosis of psoriasis using hydroxychloroquine or ultraviolet phototherapy may cause SCLE to worsen. Abstract Psoriasiform subacute cutaneous lupus erythematosus is an unusual presentation scarcely reported in literature. We report a case of a 54-year-old man who presented with an itchy, papulosquamous rash of the upper extremities and face for 7 months. The initial physical examination revealed the classical morphology of psoriasis. One and a half years after the diagnosis of clinical worsening, the patient noticed a new papular eruption on the right posterior upper arm. A skin biopsy was performed, confirming a diagnosis of subacute cutaneous lupus erythematosus. This case report highlights the importance of considering rare presentations of cutaneous lupus erythematosus and therapeutic challenges in management.
Collapse
Affiliation(s)
- Shazli Razi
- Rao DermatologyAtlantic HighlandsNew JerseyUSA
- Department of Internal MedicineJersey Shore University Medical CenterNeptuneNew JerseyUSA
| | - Thu M. Truong
- Rao DermatologyAtlantic HighlandsNew JerseyUSA
- Center for DermatologyRutgers Robert Wood Johnson Medical SchoolSomersetNew JerseyUSA
- Department of MedicineRutgers New Jersey Medical SchoolNewarkNew JerseyUSA
| | | | - Samantha Ouellette
- Rao DermatologyAtlantic HighlandsNew JerseyUSA
- Center for DermatologyRutgers Robert Wood Johnson Medical SchoolSomersetNew JerseyUSA
| | - Babar K. Rao
- Rao DermatologyAtlantic HighlandsNew JerseyUSA
- Center for DermatologyRutgers Robert Wood Johnson Medical SchoolSomersetNew JerseyUSA
- Department of DermatologyWeill Cornell MedicineNew YorkNew YorkUSA
| |
Collapse
|
6
|
Razi S, Ouellette S, Khan S, Rao B. Metastatic renal cell carcinoma presenting as multiple cutaneous lesions visualized through reflectance confocal microscopy. Clin Case Rep 2023; 11:e7486. [PMID: 37305867 PMCID: PMC10248214 DOI: 10.1002/ccr3.7486] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2023] [Accepted: 05/16/2023] [Indexed: 06/13/2023] Open
Abstract
We present the first case of metastatic renal cell carcinoma visualized via reflectance confocal microscopy (RCM). This case describes the RCM features of such a tumor, in an effort to improve noninvasive characterization of cutaneous metastases.
Collapse
Affiliation(s)
- Shazli Razi
- Rao DermatologyAtlantic HighlandsNew JerseyUSA
| | - Samantha Ouellette
- Rao DermatologyAtlantic HighlandsNew JerseyUSA
- Department of Pathology & Laboratory MedicineRutgers Robert Wood Johnson Medical School, Center for DermatologySomersetNew JerseyUSA
| | - Samavia Khan
- Rao DermatologyAtlantic HighlandsNew JerseyUSA
- Department of Pathology & Laboratory MedicineRutgers Robert Wood Johnson Medical School, Center for DermatologySomersetNew JerseyUSA
| | - Babar Rao
- Rao DermatologyAtlantic HighlandsNew JerseyUSA
- Department of Pathology & Laboratory MedicineRutgers Robert Wood Johnson Medical School, Center for DermatologySomersetNew JerseyUSA
| |
Collapse
|
7
|
Razi S, Ouellette S, Khan S, Oh KS, Truong TM, Rao BK. Role of VivaScope 2500 ex vivo confocal microscopy in skin pathology: Advantages, limitations, and future prospects. Skin Res Technol 2023; 29:e13388. [PMID: 37357649 PMCID: PMC10250963 DOI: 10.1111/srt.13388] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2023] [Accepted: 05/27/2023] [Indexed: 06/27/2023]
Abstract
BACKGROUND Vivascope 2500 ex vivo confocal microscopy (EVCM) is an emerging optical imaging device that allows nuclear level resolution of freshly excised tissues. EVCM provides, rapid real-time pathological examination in many subspecialties of pathology including skin, prostate, breast, liver, etc. In contrast to traditional time-consuming frozen sectioning and histological analysis. AIMS To evaluate the current state of EVCM utilization. MATERIALS AND METHODS This study highlights the advantages, limitations, and prospects of EVCM in skin pathology. RESULTS Our findings demonstrate that EVCM is a promising adjunctive tool to assess margins in Mohs surgery and to provide rapid, accurate diagnosis of cutaneous tumors, infectious and inflammatory diseases. CONCLUSION EVCM is a revolutionary device that can be used as an adjunct to paraffin-fixed, hematoxylin and eosin-stained slides and frozen sectioning. Additional refinements are required before EVCM can be used as an alternative to frozen sectioning or traditional tissue processing.
Collapse
Affiliation(s)
- Shazli Razi
- Department of Dermatology and PathologyRao DermatologyNew YorkNew YorkUSA
| | - Samantha Ouellette
- Department of Dermatology and PathologyRao DermatologyNew YorkNew YorkUSA
- Center for Dermatology, Robert Wood Johnson Medical SchoolRutgers UniversityNew BrunswickNew JerseyUSA
| | - Samavia Khan
- Department of Dermatology and PathologyRao DermatologyNew YorkNew YorkUSA
- Center for Dermatology, Robert Wood Johnson Medical SchoolRutgers UniversityNew BrunswickNew JerseyUSA
| | - Kei Shing Oh
- Department of Pathology and Laboratory MedicineMount Sinai Medical CenterMiami BeachFloridaUSA
| | - Thu M. Truong
- Department of Dermatology and PathologyRao DermatologyNew YorkNew YorkUSA
- Center for Dermatology, Robert Wood Johnson Medical SchoolRutgers UniversityNew BrunswickNew JerseyUSA
- Department of MedicineRutgers New Jersey Medical SchoolNewarkNew JerseyUSA
| | - Babar K. Rao
- Department of Dermatology and PathologyRao DermatologyNew YorkNew YorkUSA
- Center for Dermatology, Robert Wood Johnson Medical SchoolRutgers UniversityNew BrunswickNew JerseyUSA
| |
Collapse
|
8
|
Anwar F, Mahmood E, Sharif S, Shah R, Jamgochian M, Ouellette S, Umar M, Rao B. Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangiomas. J Drugs Dermatol 2023; 22:594-598. [PMID: 37276157 DOI: 10.36849/jdd.7054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
BACKGROUND Oral propranolol is considered the first line therapy in the treatment of infantile hemangiomas (IHs). However, there are considerable side effects due to its ability to penetrate the blood brain barrier. Alternatively, topical timolol, a non-selective beta blocker, has resulted in fewer side effects and is 4–10 times more potent in comparison to oral propranolol. This study evaluates the efficacy of 0.5% timolol maleate hydrogel for the treatment of IH. METHODS This study was conducted via a quasi-experimental design from October 30, 2020 – April 29, 2021, at the Department of Dermatology Benazir Bhutto Hospital, Rawalpindi. 145 infants between 1–12 months in age diagnosed with superficial cutaneous hemangiomas were included in the study with a male to female ratio of 2.4:1. A thin layer of timolol maleate 0.5% hydrogel was applied to the entire surface of the patient’s IH three times daily. Digital photographs and measurements of the hemangiomas were taken at one-month intervals for a maximum of 6 months. RESULTS The age range in this study was from 1–12 months with a mean age of 6.10 ± 2.52 months. The majority of the patients 89 (61.4%) were between 1–6 months of age. Of the 145 patients, 89 (61.4%) showed an excellent response, 44 (30.3%) showed a good response, and 12 (8.3%) showed no response to the topical 0.5% timolol maleate hydrogel treatment. CONCLUSION The use of topical 0.5% timolol maleate hydrogel is a promising therapeutic option for the treatment of superficial IHs. Anwar F, Mahmood E, Sharif S, et al. Topical application of 0.5% timolol maleate hydrogel for the treatment of superficial infantile hemangiomas. J Drugs Dermatol. 2023;22(6):594-598. doi:10.36849/JDD.7054.
Collapse
|
9
|
Ahmed F, Ragi SD, Moseley I, Mirza FN, Yumeen S, Vance T, Ouellette S, Rao B. Rosacea Diagnosis and Prescription Patterns in Underrepresented Groups: An All of Us Database Analysis. J Am Acad Dermatol 2023:S0190-9622(23)00531-5. [PMID: 37024052 DOI: 10.1016/j.jaad.2023.03.042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Revised: 02/27/2023] [Accepted: 03/03/2023] [Indexed: 04/08/2023]
Affiliation(s)
- Fadwa Ahmed
- The Warren Alpert Medical School of Brown University, Providence, RI.
| | - Sara D Ragi
- The Warren Alpert Medical School of Brown University, Providence, RI
| | - Isabelle Moseley
- The Warren Alpert Medical School of Brown University, Providence, RI
| | - Fatima N Mirza
- Department of Dermatology, the Warren Alpert Medical School of Brown University, Providence, RI
| | - Sara Yumeen
- Department of Dermatology, the Warren Alpert Medical School of Brown University, Providence, RI
| | - Terrence Vance
- Department of Dermatology, the Warren Alpert Medical School of Brown University, Providence, RI
| | - Samantha Ouellette
- Department of Dermatology, the Warren Alpert Medical School of Brown University, Providence, RI
| | - Babar Rao
- Department of Dermatology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
| |
Collapse
|
10
|
Ahmed F, Moseley I, Ragi SD, Ouellette S, Rao B. Vitiligo in underrepresented communities: An All of Us database analysis. J Am Acad Dermatol 2023; 88:945-948. [PMID: 36414097 DOI: 10.1016/j.jaad.2022.11.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2022] [Revised: 11/04/2022] [Accepted: 11/15/2022] [Indexed: 11/21/2022]
Affiliation(s)
- Fadwa Ahmed
- Warren Alpert Medical School of Brown University, Providence, Rhode Island
| | - Isabelle Moseley
- Warren Alpert Medical School of Brown University, Providence, Rhode Island
| | - Sara D Ragi
- Warren Alpert Medical School of Brown University, Providence, Rhode Island.
| | | | - Babar Rao
- Department of Dermatology, Robert Wood Johnson Medical School, New Brunswick, New Jersey
| |
Collapse
|
11
|
Moseley I, Ragi SD, Ouellette S, Rao B. Onychomycosis in underrepresented groups: an all of us database analysis. Arch Dermatol Res 2023; 315:647-651. [PMID: 36261664 DOI: 10.1007/s00403-022-02413-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2022] [Accepted: 10/13/2022] [Indexed: 11/28/2022]
Abstract
Few research studies evaluating the impact of dermatologic diseases in the United States (US) have adequately included underrepresented groups. All of Us (AoU) is an ongoing precision medicine-based research initiative by the National Institutes of Health (NIH) that facilitates research in populations traditionally underrepresented in biomedical research by prioritizing them for data collection. Our objective was to evaluate the burden of onychomycosis in underrepresented groups defined by the framework provided by AoU. The AoU Registered Tier dataset version 5 was used which includes data collected between May 30, 2017 and April 1, 2021. We conducted a cross-sectional analysis linking survey and electronic health record (EHR) data to estimate the prevalence of onychomycosis in underrepresented groups defined by race, ethnicity, age (≥ 75 years), disability, sexual orientation/gender identity (LGBTQIA +), income (annual household income ≤ $35 000) and education (less than a high school degree). The latest All of Us data release includes 329,038 participants. Of these, 251,597 (76%) had EHR data and 13,874 had onychomycosis (overall prevalence, 5.5%; 95% CI, 5.4-5.6). Multivariate analyses adjusted by tinea pedis, diabetes mellitus, immune compromise, nail psoriasis, and insurance status, in addition to the aforementioned variables, revealed that, compared with White participants, Black and Hispanic participants had a higher adjusted odds of onychomycosis (OR, 1.29; 95% CI, 1.23-1.36 and OR, 1.24; 95% CI, 1.17-1.31, respectively). Higher adjusted odds of onychomycosis were also observed in underrepresented groups. Our findings suggest a disproportionately high burden of onychomycosis in underrepresented groups, although further studies are needed to replicate our findings and address this disparity.
Collapse
Affiliation(s)
- Isabelle Moseley
- The Warren Alpert Medical School of Brown University, 222 Richmond Street, Providence, RI, 02903, USA.
| | - Sara D Ragi
- The Warren Alpert Medical School of Brown University, 222 Richmond Street, Providence, RI, 02903, USA
| | - Samantha Ouellette
- Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, 08901, USA
| | - Babar Rao
- Department of Dermatology, Robert Wood Johnson Medical Centre, Rutgers University, New Brunswick, NJ, 08901, USA
| |
Collapse
|
12
|
Moseley I, Ragi SD, Ouellette S, Rao B. Condyloma acuminata in under-represented groups: an All of Us database analysis. Sex Transm Infect 2022; 98:620-621. [PMID: 35428700 DOI: 10.1136/sextrans-2022-055467] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2022] [Accepted: 04/02/2022] [Indexed: 12/15/2022] Open
Affiliation(s)
- Isabelle Moseley
- Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
| | - Sara D Ragi
- Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
| | - Samantha Ouellette
- Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA
| | - Babar Rao
- Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA
| |
Collapse
|
13
|
Ouellette S, Shah R, Razi S, Ashforth G, Wassef C. Fatal low-dose methotrexate toxicity: A case report and literature review. Dermatol Ther 2022; 35:e15945. [PMID: 36259229 DOI: 10.1111/dth.15945] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2022] [Revised: 10/12/2022] [Accepted: 10/17/2022] [Indexed: 12/01/2022]
Abstract
Methotrexate (MTX) is a chemotherapeutic agent that acts primarily by inhibiting the folic acid cycle. In addition to its application for treating malignancies, MTX is also used to treat chronic inflammatory diseases including psoriasis. Adverse effects have been reported even at low doses (up to 25 mg/week), and there is risk of toxicity in the form of myelosuppression, hepatotoxicity, or pulmonary fibrosis. Here, we report a case of a 67-year-old male with a past medical history of end stage renal disease on peritoneal dialysis and moderate-to-severe psoriasis with psoriatic arthritis presented with abdominal pain, diarrhea, rash, mucositis, and mucocutaneous ulcers and erosions. The patient was taking methotrexate 10 mg weekly without folic acid supplementation and was found to be pancytopenic. Despite treatment, the patient developed multiorgan failure and passed away after 16 days of hospitalization. Myelosuppression is considered the most serious side effect with the highest risk of mortality. Risk factors for toxicity include renal insufficiency, advanced age, lack of folate supplementation, drug interactions, and medication errors. Importantly, serum levels of MTX do not correlate with toxicity; therefore, folinic acid rescue therapy should be started as soon as MTX toxicity is suspected. MTX toxicity is rare with low dose, proper dose scheduling, and adherence to the recommended guidelines. It is imperative that physicians considering therapy with low dose MTX for dermatologic indications take into consideration a patient's risk factors for toxicity and monitor appropriately.
Collapse
Affiliation(s)
- Samantha Ouellette
- Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA
| | - Rohan Shah
- Division of Dermatology, Rutgers New Jersey Medical School, Newark, New Jersey, USA
| | | | - Gina Ashforth
- Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA
| | - Cindy Wassef
- Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA
| |
Collapse
|
14
|
Razi S, Bhardwaj V, Ouellette S, Khan S, Azadegan C, Boyd T, Rao B. Demystifying the mechanism of action of professional facial peeling: In-vivo visualization and quantification of changes in inflammation, melanin and collagen using Vivascope® and ConfoScan®. Dermatol Ther 2022; 35:e15846. [PMID: 36129212 PMCID: PMC9787425 DOI: 10.1111/dth.15846] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2022] [Accepted: 09/16/2022] [Indexed: 12/30/2022]
Abstract
Professional peeling using chemicals (chemical peeling) is a popular non-surgical procedure commonly used for the treatment for photoaging, pigmentary disorders, scarring, fine lines, and wrinkles. The objective of our case study was to elucidate the mechanism of action of professional peels/peeling. For proof-of-concept, we used a commercial blended peel containing trichloroacetic acid and lactic acid. The facial peeling was performed by a physician on four subjects. These subjects were followed over time in the clinic to take clinical pictures and monitor surface and anatomical changes in inflammation, melanin, and collagen at regular intervals post-peel (5 min, 48 h, and day 9). Dermoscope and Vivascope® were used to image surface and subsurface anatomical changes, respectively, and ConfoScan® was used to quantify aforementioned anatomical changes. Based on Vivascope and ConfoScan analysis, we could see clear visual clinical evidence of controlled injury-healing mechanism of peel's action: immediate but transient onset of inflammation within 5 min (indicate injury response by skin), followed by melanin redistribution evident at 48 h (indicate activation of skin's defense system), and remodeled fibrous collagen network without any inflammatory cells on day 9 (healing response). To our knowledge, this is the first ever clinical study to deconvolute the mysterious mechanism of action of peels, in-vivo.
Collapse
Affiliation(s)
- Shazli Razi
- Department of Dermatology and PathologyRao DermatologyAtlantic HighlandsNew JerseyUSA
| | - Vinay Bhardwaj
- Department of Global Personal Care and Skin Health R&DColgate‐PalmolivePiscatawayNew JerseyUSA
| | - Samantha Ouellette
- Department of Dermatology and PathologyRao DermatologyAtlantic HighlandsNew JerseyUSA,Robert Wood Johnson Medical CenterRutgers UniversityNew BrunswickNew JerseyUSA
| | - Samavia Khan
- Department of Dermatology and PathologyRao DermatologyAtlantic HighlandsNew JerseyUSA,Robert Wood Johnson Medical CenterRutgers UniversityNew BrunswickNew JerseyUSA
| | - Chloe Azadegan
- Department of Global Personal Care and Skin Health R&DColgate‐PalmolivePiscatawayNew JerseyUSA,School of Arts and SciencesCell Biology and NeuroscienceNew BrunswickNew JerseyUSA
| | - Thomas Boyd
- Department of Global Personal Care and Skin Health R&DColgate‐PalmolivePiscatawayNew JerseyUSA
| | - Babar Rao
- Department of Dermatology and PathologyRao DermatologyAtlantic HighlandsNew JerseyUSA,Robert Wood Johnson Medical CenterRutgers UniversityNew BrunswickNew JerseyUSA
| |
Collapse
|
15
|
Ouellette S, Razi S, Haroon A. 34774 Assessing penetration, delivery, and mode of action of dissolving microneedle patches for reducing under-eye wrinkles using reflectance confocal microscopy. J Am Acad Dermatol 2022. [DOI: 10.1016/j.jaad.2022.06.105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
16
|
Ragi SD, Moseley I, Ouellette S, Rao B. Epidemiology and Survival of Kaposi's Sarcoma by Race in the United States: A Surveillance, Epidemiology, and End Results Database Analysis. Clin Cosmet Investig Dermatol 2022; 15:1681-1685. [PMID: 36003526 PMCID: PMC9394645 DOI: 10.2147/ccid.s380167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2022] [Accepted: 08/13/2022] [Indexed: 11/26/2022]
Abstract
The introduction of highly active antiretroviral treatment (HAART) for acquired immunodeficiency syndrome (AIDS) has led to a significant decrease in the incidence of Kaposi’s sarcoma (KS) in recent years. However, a concomitant increase in racial disparities in KS has arisen. Here, we analyze data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Program for epidemiology and survival of Kaposi’s sarcoma by race. The highest incidence was observed among Black patients (incidence rate (IR), 1.189; 95% confidence interval (CI), 1.092–1.189), followed by White patients (IR, 0.486; 95% CI, 0.473–0.498). Relative survival at 1, 3, and 5 years differed significantly by race, with White patients having the highest survival rates (84.26%, 77.79%, and 74.79% at 1, 3, and 5 years respectively) and Black patients demonstrating the lowest (71.50%, 61.37%, and 57.38%), with intermediate survival rates in Asians/Pacific Islanders (AAPI) (80.62%, 71.19%, and 67.28%) and American Indians/Alaska Natives (AIAN) (80.56%, 61.45%, and 61.45%). We conclude that there are significant racial disparities in the incidence, epidemiology, and survival of KS.
Collapse
Affiliation(s)
- Sara D Ragi
- The Warren Alpert Medical School of Brown University, Providence, RI, USA
| | - Isabelle Moseley
- The Warren Alpert Medical School of Brown University, Providence, RI, USA
| | - Samantha Ouellette
- Department of Dermatology, Robert Wood Johnson Medical School, New Brunswick, NJ, USA
| | - Babar Rao
- Department of Dermatology, Robert Wood Johnson Medical School, New Brunswick, NJ, USA
| |
Collapse
|
17
|
Moseley I, Ragi SD, Ouellette S, Rao B. Tinea Pedis in Underrepresented Groups: An All of Us Database Analysis. Mycoses 2022; 66:29-34. [PMID: 35997514 DOI: 10.1111/myc.13522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2022] [Revised: 08/11/2022] [Accepted: 08/21/2022] [Indexed: 11/29/2022]
Abstract
BACKGROUND Tinea pedis is the most common form of dermatophytosis resulting in interdigital infections. All of Us (AoU) is a National Institute of Health initiative with an emphasis on patient populations traditionally underrepresented in biomedical research. OBJECTIVES Our objective was to evaluate the burden of tinea pedis in underrepresented groups in the United States, utilizing the novel AoU research program. METHODS We analyzed AoU Registered Tier dataset version 5, which includes data collected between May 30, 2017 and April 1, 2021. We conducted a cross-sectional analysis linking survey and electronic health record (EHR) data to estimate the prevalence of tinea pedis in underrepresented groups. RESULTS AoU data release includes 329,038 participants. Of these, 251,597 (76.5%) had electronic health record data and 6,932 had tinea pedis (overall prevalence, 2.76%; 95% CI, 2.69-2.82). Multivariate analyses revealed that, compared with White participants, Black and Hispanic participants had a higher adjusted odds of tinea pedis (OR, 1.29; 95% CI, 1.20-1.38 and OR, 1.38; 95% CI, 1.28-1.48, respectively). Higher adjusted odds of tinea pedis were observed in underrepresented groups defined by: age >=75 years (OR, 1.45; 95% CI, 1.33-1.57), LGBTQ status (OR, 1.17; 95% CI, 1.09-1.27), less than a high school education (OR, 1.22; 95% CI, 1.11-1.34), income <$35 000 (OR, 1.09; 95% CI, 1.02-1.16), and physical disability (OR, 1.56; 95% CI, 1.08-1.24). CONCLUSIONS Our findings are consistent with overall age, and gender-specific prevalence estimates from prior epidemiologic studies, validating the scientific consistency of the new AoU database. Additionally, there may be an increased burden of tinea pedis among Black and Hispanic individuals.
Collapse
Affiliation(s)
- Isabelle Moseley
- The Warren Alpert Medical School of Brown University, Providence, RI
| | - Sara D Ragi
- The Warren Alpert Medical School of Brown University, Providence, RI
| | - Samantha Ouellette
- Robert Wood Johnson Medical School, Department of Dermatology, New Brunswick, NJ
| | - Babar Rao
- Robert Wood Johnson Medical School, Department of Dermatology, New Brunswick, NJ
| |
Collapse
|
18
|
Razi S, Oh K, Ouellette S, Rao B. LB921 Role of VivaScope ® 2500 in skin pathology: Advantages, limitations, and future prospects. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.939] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
19
|
Razi S, Ouellette S, Rao B. LB951 Assessing penetration, delivery, and mode of action of dissolving microneedle patches for reducing under-eye wrinkles using reflectance confocal microscopy. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.970] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
20
|
Moseley I, Ragi SD, Ouellette S, Rao B. Tinea versicolour in underrepresented groups: An All of Us database analysis. Skin Health Dis 2022; 3:e152. [PMID: 36751318 PMCID: PMC9892469 DOI: 10.1002/ski2.152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
Tinea versicolour, used interchangeably with pityriasis versicolour (PV), is a superficial fungal infection of the stratum corneum caused by Malassezia furfur, a fungus of the normal flora of the skin. PV occurs when conditions favour proliferation of the organism's mycelial form, such as in environments with high temperatures/humidity, in immunodeficient/immunocompromised states, and during pregnancy. PV presents as numerous well- demarcated macules with a powdery scale. Prior epidemiologic studies have indicated that underrepresented groups defined by race experience a higher burden of PV as compared to White patients. However, the burden of PV in other underrepresented groups has not previously been examined, as underrepresented groups are frequently excluded from studies evaluating the impact of dermatologic disease. The new National Institute of Health All of Us Research Program (AoU) aims to build one of the world's largest and most diverse databases to promote elucidation of health disparities, particularly in communities that have been historically excluded from biomedical research.
Collapse
Affiliation(s)
- Isabelle Moseley
- The Warren Alpert Medical School of Brown UniversityProvidenceRIUSA
| | - Sara D. Ragi
- The Warren Alpert Medical School of Brown UniversityProvidenceRIUSA
| | - Samantha Ouellette
- Department of DermatologyRobert Wood Johnson Medical SchoolNew BrunswickNJUSA
| | - Babar Rao
- Department of DermatologyRobert Wood Johnson Medical SchoolNew BrunswickNJUSA
| |
Collapse
|
21
|
Ouellette S, Frias G, Shah R, Alamgir M, Wassef C. Laser in the Treatment of Granulomas on the Nose Produced by Polymethylmethacrylate: A Case Series. J Drugs Dermatol 2021; 22:413-416. [PMID: 37026881 DOI: 10.36849/jdd.6550] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
BACKGROUND The search for aesthetic non-surgical procedures is growing. The use of polymethylmethacrylate (PMMA) as a filling material in the nose represents one of the many options among these aesthetic procedures. Its use, however, can lead to complications. The treatment of these complications is often challenging. METHODS We performed a retrospective clinical analysis of the medical records of patients undergoing treatment of PMMA granulomas of the nose at a private clinic from January, 2015, to January, 2021. A short-pulsed neodymium-YAG (Nd:YAG) laser was applied intranasally or directly by cutaneous incision in the granulomas. Laser-tissue interaction heats the alloplastic material, fragments the product and creates cleavage paths, thereby facilitating the removal of PMMA, either by intercartilaginous removal or aspiration. RESULTS Twenty-seven patients were included in the study. All had a history of PMMA injection in the nose. All patients were treated with an intralesional pulsed 1064nm Nd:YAG laser. The material removed after laser-tissue interaction was sent for histopathological examination; this showed the presence of microparticles of exogenous material compatible with PMMA. The partial removal of the alloplastic material was shown to be effective in all cases. One patient developed a small blister in the nasal dorsum. Follow-up ranged from six to 47 months. CONCLUSIONS The use of intralesional Nd:YAG laser for the treatment of PMMA granulomas on the nose proved to be an effective and safe procedure with improvement of nasal shape, without compromising respiratory function. This technical option represents yet another alternative in the treatment of PMMA granuloma complications. J Drugs Dermatol. 2021;20(11): 1161-1166. doi:10.36849/JDD.6550.
Collapse
|
22
|
Van De Riet J, Gibbs RS, Muggah PM, Rourke WA, MacNeil JD, Quilliam MA, Aasen J, Amzil; B. Ben Gigirey Z, Burdaspal P, Burrell SW, Brazeau J, Carter SJ, Ceredi A, Duffy C, Eaglesham G, Hatfeld R, Hillyard T, Jensen MKH, Lacaze JP, Langlois D, Legarda TM, Marcos E, Milandri A, Mulder PPJ, Murphy C, Ouellette S, Panganiban C, Pante L, Paulsrud MS, Pooley BP, Reeves K, Riccardi E, Rodríguez Velasco ML, Sacrey TZ, Savar V, Selwood A, Sizoo EA, Turner AD, van Ginkel R, Wotherspoon ATL. Liquid Chromatography Post-Column Oxidation (PCOX) Method for the Determination of Paralytic Shellfish Toxins in Mussels, Clams, Oysters, and Scallops: Collaborative Study. J AOAC Int 2019. [DOI: 10.1093/jaoac/94.4.1154] [Citation(s) in RCA: 73] [Impact Index Per Article: 14.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Abstract
Sixteen laboratories participated in a collaborative study to evaluate method performance parameters of a liquid chromatographic method of analysis for paralytic shellfsh toxins (PST) in blue mussels (Mytilus edulis), soft shell clams (Mya arenaria), sea scallops (Placopectin magellanicus), and American oysters (Crassostrea virginicus). The specifc analogs tested included saxitoxin, neosaxitoxin, gonyautoxins-1 to -5, decarbamoyl-gonyautoxins-2 and -3, decarbamoyl-saxitoxin, and N-sulfocarbamoylgonyautoxin-2 and -3. This instrumental technique has been developed as a replacement for the current AOAC biological method (AOAC Offcial MethodSM 959.08) and an alternative to the pre-column oxidation LC method (AOAC Offcial MethodSM 2005.06). The method is based on reversed-phase liquid chromatography with post-column oxidation and fluorescence detection (excitation 330 nm and emission 390 nm). The shellfsh samples used in the study were prepared from the edible tissues of clams, mussels, oysters, and scallops to contain concentrations of PST representative of low, medium, and high toxicities and with varying profles of individual toxins. These concentrations are approximately equivalent to ½ maximum level (ML), ML, or 2×ML established by regulatory authorities (0.40, 0.80, and 1.60 mg STX·diHCl eq/kg, respectively). Recovery for the individual toxins ranged from 104 to 127%, and recovery of total toxin averaged 116%. Horwitz Ratio (HorRat) values for individual toxins in the materials included in the study were generally within the desired range of 0.3 to 2.0. For the estimation of total toxicity in the test materials, the reproducibility relative standard deviation ranged from 4.6 to 20%. A bridging study comparing the results from the study participants using the post-column oxidation (PCOX) method with the results obtained in the study director’s laboratory on the same test materials using the accepted reference method, the mouse bioassay (MBA; AOAC Offcial MethodSM 959.08), showed that the average ratio of results obtained from the two methods was 1.0. A good match of values was also achieved with a new certifed reference material. The results from this study demonstrated that the PCOX method is a suitable method of analysis for PST in shellfsh tissue and provides both an estimate of total toxicity, equivalent to that determined using the MBA AOAC Offcial MethodSM 959.08, and a detailed profle of the individual toxin present in the sample.
Collapse
Affiliation(s)
- Jeffrey Van De Riet
- Canadian Food Inspection Agency, Dartmouth Laboratory, 1992 Agency Dr, Dartmouth, NS, Canada B3B 1Y9
| | - Ryan S Gibbs
- Canadian Food Inspection Agency, Dartmouth Laboratory, 1992 Agency Dr, Dartmouth, NS, Canada B3B 1Y9
| | - Patricia M Muggah
- Canadian Food Inspection Agency, Dartmouth Laboratory, 1992 Agency Dr, Dartmouth, NS, Canada B3B 1Y9
| | - Wade A Rourke
- Canadian Food Inspection Agency, Dartmouth Laboratory, 1992 Agency Dr, Dartmouth, NS, Canada B3B 1Y9
| | - James D MacNeil
- Canadian Food Inspection Agency, Dartmouth Laboratory, 1992 Agency Dr, Dartmouth, NS, Canada B3B 1Y9
| | - Michael A Quilliam
- National Research Council of Canada, Institute of Marine Biosciences, 1411 Oxford St, Halifax, NS, Canada B3H 3Z1
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Ramsey KH, Miranpuri GS, Sigar IM, Ouellette S, Byrne GI. Chlamydia trachomatis persistence in the female mouse genital tract: inducible nitric oxide synthase and infection outcome. Infect Immun 2001; 69:5131-7. [PMID: 11447195 PMCID: PMC98609 DOI: 10.1128/iai.69.8.5131-5137.2001] [Citation(s) in RCA: 54] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
It was previously reported that female mice resolve a primary Chlamydia trachomatis urogenital infection independent of inducible nitric oxide synthase (iNOS). We now report that although iNOS-deficient (NOS2(-/-)) mice resolve culture-apparent infection in a fashion similar to that of normal control (NOS2(+/+)) mice, they sustain significantly increased rates of disease, as assessed by hydrosalpinx formation. PCR amplification of ompA followed by Southern blot detection of amplicands revealed the presence of chlamydial DNA in the lower genital tracts of both NOS2(-/-) and NOS2(+/+) mice at > or =120 days postinfection and in upper genital tract tissues at >120 days postinfection. However, only NOS2(-/-) mice shed low numbers of viable chlamydiae from the lower genital tract after immunosuppressive treatment at 120 days postinfection. When cultured primary murine lung fibroblasts were activated in the presence of gamma interferon (IFN-gamma), inhibition of chlamydial growth occurred in both NOS2(+/+) and NOS2(-/-) cells, but the inhibition was reversible after removal of the cytokine in the NOS2(-/-) primary cell culture only. The iNOS-independent inhibition was microbistatic but was independent of 2,3-indoleamine dioxygenase activity. We conclude that chlamydial DNA and antigens persist in mice subsequent to culture-apparent resolution. In addition, IFN-gamma induces in vivo inhibition of chlamydial growth through microbistatic mechanisms in the absence of iNOS activity, but in the presence of iNOS activity, IFN-gamma is microbicidal and effects eradication.
Collapse
Affiliation(s)
- K H Ramsey
- Microbiology Department, Chicago College of Osteopathic Medicine, Midwestern University, Downers Grove, Illinois 60515, USA.
| | | | | | | | | |
Collapse
|
24
|
Sherman DW, Ouellette S. Moving beyond fear: lessons learned through a longitudinal review of the literature regarding health care providers and the care of people with HIV/AIDS. Nurs Clin North Am 1999; 34:1-48. [PMID: 9922278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/10/2023]
Abstract
This article examines the literature regarding the health care provider/AIDS patient relationship for a 14 year period from 1984 through 1998. For each of the four time periods (1984-1989, 1990-1992, 1992-1995, 1996-1998), we present the general themes and concerns of the literature at that time. We begin the review of each time period with a depiction of what was happening in biomedical circles and in the broader society around HIV/AIDS. To provide a closer look at the setting for the work completed within each time period, we draw on research interviews conducted by the first author with nurses involved in AIDS care since the early days of the epidemic. Nurses'retrospective comments on what it was like to do the work at various times reveal the local reality and provide an important rationale for the work that we review. Each time period closes with a discussion of the lessons learned and suggestions of new possibilities for future efforts to enhance the well-being of both health care providers and patients with HIV/AIDS.
Collapse
Affiliation(s)
- D W Sherman
- Division of Nursing, New York University, School of Education, New York 10012, USA
| | | |
Collapse
|
25
|
Abstract
A limited T-cell receptor (TCR) Vbeta repertoire employed by autoreactive T cells may be related to the development and course of autoimmune diseases. Vbeta repertoire skewing has been observed not only in man, but also in animal models of several human autoimmune diseases, such as MRL-lpr mice, which spontaneously develop a systemic lupus erythematosus (SLE)-like disease. Murine chronic graft-versus-host disease (GVHD) is an inducible model for SLE, involving direct interaction between donor T cells and recipient B cells. It is not known whether Vbeta-specific T-cell subsets are pathogenically involved in this model. Retroviral superantigens such as Mls-1 are known to have a profound impact on the TCR Vbeta repertoire in mice. Restriction of the peripheral TCR repertoire may result from intrathymic expression of Mls-1, which causes deletion of T cells expressing Vbeta6, -7, -8.1, or -9. Mls-1 incompatibility between donor and recipient can be used to determine the involvement of these TCR Vbeta families in GVHD. In the present study we induced GVHD in several strain combinations to investigate TCR Vbeta gene expression during GVHD, and the effect of Mls-1 incompatibility on the TCR Vbeta repertoire. TCR Vbeta gene expression was determined using an RNase protection assay. Our results indicate that T cells expressing the Vbeta2 or Vbeta16 chain play an important pathogenetic role, while T cells bearing the Vbeta1 or Vbeta6 chain may be related to self-limitation of the lupus-like disease in this model.
Collapse
Affiliation(s)
- M Sutmuller
- Department of Pathology, Leiden University Hospital, The Netherlands
| | | | | | | | | |
Collapse
|
26
|
Abstract
Susceptibility to systemic lupus erythematosus (SLE) and, in particular, lupus nephritis is strongly influenced by genetic factors. Previous studies have shown that MHC-related antigens influence the development of SLE. In the current study, we set out to investigate how non-MHC genes influence the pathogenesis of glomerulonephritis in chronic graft-versus-host disease (GVHD) in mice, a model for lupus nephritis. For the induction of GVHD we used parent-to-F1 hybrid mouse strain combinations. DBA/2, BALB/c, BALB.D2 and C57B1/10.D2 (BL10.D2) donor lymphocytes carrying an H-2d haplotype were injected into H-2b/d F1 hybrids of BL10 mice, which differed only at non-MHC loci. Within these hybrid strains the development of immune complex glomerulonephritis was investigated by monitoring the occurrence of autoantibodies in the circulation, deposition of immunoglobulins in the glomeruli, development of albuminuria, and glomerulosclerosis. In diseased DBA/2 mice albuminuria developed 6 weeks after induction of the disease. Mice with a BALB background developed a lupus-like syndrome characterized by albuminuria starting 8 weeks after induction of the GVHD. During the development of the GVHD, polyclonal B cell activation occurred in both the DBA/2 and BALB/c strains, resulting in the formation of autoantibodies. Only the strain combination using DBA/2 mice developed anti-GBM antibodies. In DBA/2 and BALB strain combinations immune complexes were detected in a granular pattern along the glomerular capillary walls. In the DBA/2 recipients a linear pattern of immunoglobulin depositions preceded the granular phase. This study demonstrates that: (i) non-MHC genes govern the pathogenesis of immune complex nephritis in this model by influencing the autoantibody profile; and (ii) the presence of anti-GBM antibodies in the early stages of the disease is a conditio sine qua non for the development of full-blown glomerulonephritis and glomerulosclerosis in this model.
Collapse
Affiliation(s)
- M Sutmuller
- Department of Pathology, University of Leiden, The Netherlands
| | | | | | | | | |
Collapse
|
27
|
Cassel JB, Ouellette S. A typology of AIDS volunteers. AIDS Educ Prev 1995; 7:80-90. [PMID: 8664100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
Based on our research of volunteers at Gay Men's Health Crisis (GMHC) in New York City, we developed a typology of AIDS volunteers derived from their responses to our Reasons for Volunteering scale. The scale included six basic reasons, three of which were AIDS-specific and three of which represented more general reasons for doing volunteer work. Cluster analysis was used to identify sub-groups in this sample, from which we identified seven distinct and meaningful types of volunteers. One type, which we labeled Self-Sacrificers, is the closest we could find to a group of altruists-volunteers who indicated that self-gain was unimportant to them. While the volunteers who endorsed AIDS-related reasons for volunteering were most likely to be gay men and to have had significant prior AIDS-related experiences, each cluster was markedly heterogeneous in terms of demographic characteristics. Implications are drawn for the management of volunteers in community-based AIDS organizations and for further research on helping behavior and altruism.
Collapse
Affiliation(s)
- J B Cassel
- GMHC Department of Evaluation Research, New York, NY 10011, USA
| | | |
Collapse
|
28
|
Davignon J, Dufour R, Roy M, Bétard C, Ma Y, Ouellette S, Boulet L, Lussier-Cacan S. Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred. Eur J Epidemiol 1992; 8 Suppl 1:10-7. [PMID: 1505645 DOI: 10.1007/bf00145344] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Of 163 individuals with a diagnosis of heterozygous familial hypercholesterolemia (FH), only one subject was found to be positive for familial defective apo B-100 (FDB). The eight-member kindred ascertained through this subject who presented with both a clinical phenotype of FH and the FDB apo B-100 (Arg3500----Gln) mutation was studied. Plasma lipid and lipoprotein profiles, apo E phenotypes, apo B gene markers at the 3' hypervariable region and LDL-receptor haplotypes (ApaLI, PvuII, NcoI), were determined, together with LDL-receptor activity on freshly isolated blood lymphocytes. The FDB mutation, present in four relatives, was associated with three different phenotypes: FH and severe hypercholesterolemia, moderate hypercholesterolemia and normolipidemia. The FH phenotype occurred in the absence of any functional LDL-receptor defect. In homozygotes for the absence of the PvuII cutting site who had the apo B mutation, LDL-cholesterol levels were low in the presence of the apo E3/2 phenotype and high in the presence of the apo E4/4 phenotype. None of the major known environmental influences accounted for the wide range of variation in LDL-cholesterol among the affected members. Further observations in the spouse and offspring of the normolipidemic FDB subject confirmed the association of apo E4, the FDB mutation and the PvuII(-/-) genotype with high cholesterol levels. It is concluded that the phenotypic expression of the FDB mutation may vary widely as a function of the genetic environment within a family.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- J Davignon
- Hyperlipidemia and Atherosclerosis Research Group, Clinical Research Institute of Montreal, Quebec, Canada
| | | | | | | | | | | | | | | |
Collapse
|
29
|
Kessling A, Ouellette S, Bouffard O, Chamberland A, Bétard C, Selinger E, Xhignesse M, Lussier-Cacan S, Davignon J. Patterns of association between genetic variability in apolipoprotein (apo) B, apo AI-CIII-AIV, and cholesterol ester transfer protein gene regions and quantitative variation in lipid and lipoprotein traits: influence of gender and exogenous hormones. Am J Hum Genet 1992; 50:92-106. [PMID: 1346081 PMCID: PMC1682540] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/25/2023] Open
Abstract
Patterns of RFLP association were studied, to identify gene regions influencing quantitative variation in lipid and lipoprotein traits (coronary artery disease [CAD] risk factors or metabolically related traits). Subjects (118 female and 229 male; age 20-59 years) were selected for health. Multiple RFLPs were used to sample variability in regions around genes for apolipoprotein (apo) B (restriction enzymes HincII, PvuII, EcoRI, and XbaI), apo AI-CIII-AIV (BamHI, XmnI, TaqI, PstI, SstI, and PvuII) and cholesterol ester transfer protein (TaqI). Separate analyses were done by gender. The sample was truncated at mean +/- 4 SD, to remove extreme outliers. There was no significant gender difference in RFLP genotype frequency distribution. After trait-level adjustment to maximize removal of concomitant variability, analysis of variance was used to estimate the percentage trait phenotypic variance explained by measured variability in the gene regions studied. Fewer gene regions were involved in men, with less influence on quantitative trait variation than in women, in whom hormone use affected association patterns. Gender differences imply that pooling genders or adjusting data for gender effects removes genetic information and should be avoided. The association patterns show that variability around the candidate genes modulates trait levels: the genes are contributors to the genetics of CAD risk variables in a healthy sample.
Collapse
Affiliation(s)
- A Kessling
- Hyperlipidemia and Atherosclerosis Research Group, Institut de Recherches Cliniques de Montréal
| | | | | | | | | | | | | | | | | |
Collapse
|